« Previous
Next »
Titles
- A resource guide for using Medicare’s enrollment race and ethnicity data1
- A risk-based approach to monitoring of clinical investigations questions and answers: guidance for industry1
- Achieving behavioral health care integration in rural America1
- Action level for inorganic arsenic in apple juice: guidance for industry1
- Addressing the direct care workforce shortage: a bipartisan call to action1
- Adjusting for covariates in randomized clinical trials for drugs and biological products: guidance for industry1
- Advancing primary prevention in human services. Key considerations for administrators and practitioners1
- Advancing primary prevention in human services. Key considerations for policy designers and funding partners1
- Advancing primary prevention in human services. Opportunities for people with lived experience1
- Advancing primary prevention in human services: convening findings1
- Advancing research on intersections of child welfare and Medicaid using linked data from the CCOULD project1
- Adverse events toolkit. Clinical guidance for identifying harm1
- Adverse events toolkit. Medical record review methodology1
- Alternative payment models and the slowdown in federal health care spending: testimony before the Committee on the Budget, United States Senate1
- Alternative procedures for the manufacture of cold-stored platelets intended for the treatment of active bleeding when conventional platelets are not available or their use is not practical: guidance for industry1
- Animal use in research: NIH should strengthen oversight of projects it funds at foreign facilities : report to congressional requesters1
- Annual status report information and other submissions for postmarketing requirements and commitments: using forms FDA 3988 and FDA 3989 : guidance for industry1
- Antibiotic resistance: Federal agencies have taken steps to combat the threat, but additional actions needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives1
- Antimicrobial susceptibility test (AST) system devices: updating breakpoints in device labeling : guidance for industry and Food and Drug Administration staff1
- Antiviral drugs: Economic incentives and strategies for pandemic preparedness : report to congressional committees1